TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23333777

Group type: EXPERIMENTAL
Intervention: Plerixafor plus G-CSF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus G-CSF
Number of subjects: 0
Study: 21392395

Group type: EXPERIMENTAL
Intervention: Enteral nutrition (EN) within 24 hours of onset
Number of subjects: 208

Group type: COMPARATOR
Intervention: Oral diet and EN if necessary after 72 hours after hospital admission
Number of subjects: 208
Study: 19145396

Group type: EXPERIMENTAL
Intervention: Ibandronate (150 mg, once-monthly)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 17640547

Group type: EXPERIMENTAL
Intervention: Regional myocardial delivery of autologous cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 16509251

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 412

Group type: COMPARATOR
Intervention: Control group (non-tuberculosis and leprosy conditions)
Number of subjects: 412
Study: 11490418

Group type: EXPERIMENTAL
Intervention: Doxicyclin 200 mg/day with nistatine for three weeks with 3‐week interval between the courses and bifidum‐bacterin administration between the courses and after the treatment
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Biseptol 1920 mg for 3 weeks then 960 mg 10 days a month
Number of subjects: 65

Group type: COMPARATOR
Intervention: No antibacterial drugs
Number of subjects: 65
Study: 9990420

Group type: EXPERIMENTAL
Intervention: Adapalene 0.1% solution
Number of subjects: 297

Group type: COMPARATOR
Intervention: Tretinoin 0.025% gel
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Adapalene 0.1% solution and Tretinoin 0.025% gel
Number of subjects: 297
Study: 8092895

Group type: EXPERIMENTAL
Intervention: Surgical therapy
Number of subjects: 393

Group type: COMPARATOR
Intervention: Thrombolysis (rt-PA or UK)
Number of subjects: 393

Group type: COMPARATOR
Intervention: Thrombolysis
Number of subjects: 393
Study: 29529387

Group type: EXPERIMENTAL
Intervention: Low-intensity stretching (30%-40% maximum perceived stretch)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High-intensity stretching (70%-80% maximum perceived stretch)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no stretching)
Number of subjects: 30
Study: 26893095

Group type: EXPERIMENTAL
Intervention: Paclitaxel coated balloon (PCB) angioplasty
Number of subjects: 110

Group type: COMPARATOR
Intervention: Plain old balloon angioplasty (POBA)
Number of subjects: 110
Study: 24533510

Group type: EXPERIMENTAL
Intervention: Unopposed estrogen (estradiol valerate: 2 mg for 2 years)
Number of subjects: 1017

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1017

Group type: EXPERIMENTAL
Intervention: Unopposed estrogen
Number of subjects: 1017
Study: 23866906

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (30 minutes with a mixed current of 2 Hz/120 Hz at 80% of bearable intensity) at 12 standard acupuncture points, twice per week for eight weeks (total of 16 sessions)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham electroacupuncture (no electrical current, but visual and auditory cues) at non‐acupuncture points
Number of subjects: 45

Group type: COMPARATOR
Intervention: Usual care (no electroacupuncture treatment)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 45

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 45
Study: 20593240

Group type: EXPERIMENTAL
Intervention: Rofecoxib (selective COX-2 inhibitor)
Number of subjects: 38
Study: 17953786

Group type: EXPERIMENTAL
Intervention: Profile B (aroma profile during consumption of (soft) solids)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Sweet strawberry aroma stimulation
Number of subjects: 27
Study: 16981843

Group type: EXPERIMENTAL
Intervention: Recent smokers (current smokers or those who quit less than 10 years ago)
Number of subjects: 1549

Group type: EXPERIMENTAL
Intervention: Smokers who smoked more than 20 cigarettes per day
Number of subjects: 1549

Group type: EXPERIMENTAL
Intervention: NAT2 phenotypic activity (0: slow, 1: intermediate, 2: rapid)
Number of subjects: 1549

Group type: EXPERIMENTAL
Intervention: Recent smokers with NAT2*4/*5B diplotype
Number of subjects: 1549

Group type: EXPERIMENTAL
Intervention: Recent smokers with NAT2*4/*4 diplotype
Number of subjects: 1549

Group type: EXPERIMENTAL
Intervention: Smokers with NAT1*4/*10 diplotype
Number of subjects: 1549
Study: 12702191

Group type: EXPERIMENTAL
Intervention: WBC-reduced RBCs (n = 25)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Nonfiltered blood (n = 27)
Number of subjects: 52
Study: 11168669

Group type: EXPERIMENTAL
Intervention: 0.5% gentian violet applied once a day for skin lesions (28 cases)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 0.3% gentian violet applied twice a day for nasal lesions (9 cases)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Gentian violet (MIC against MRSA)
Number of subjects: 37
Study: 8779402

Group type: EXPERIMENTAL
Intervention: 8 ml bupivacaine 0.25% + 0.1 mg fentanyl (B + F group)
Number of subjects: 53

Group type: COMPARATOR
Intervention: 8 ml bupivacaine 0.25% + 2 ml saline (BUP group)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: B + F group
Number of subjects: 53

Group type: COMPARATOR
Intervention: BUP group
Number of subjects: 53
Study: 1549942

Group type: EXPERIMENTAL
Intervention: Isoflurane (mean duration 40 min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Alfentanil-methohexitone (30 min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Propofol (30 min)
Number of subjects: 21
Study: 4089013

Group type: EXPERIMENTAL
Intervention: Pimozide
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 31105044

Group type: EXPERIMENTAL
Intervention: Ultra-processed diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unprocessed diet
Number of subjects: 20
Study: 29601997

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) restricted diet (<25:>50:25% daily calories from CHO: fat: protein)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fat restricted diet (55:20:25% daily calories from CHO: fat: protein)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) restricted diet
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fat restricted diet
Number of subjects: 40
Study: 27814861

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) with unloading techniques on the piriformis muscle, applied for three days
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51
Study: 24641783

Group type: EXPERIMENTAL
Intervention: Powered rotating-oscillating toothbrush with repeated oral hygiene instructions (OHI) and motivation (Group E1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Manual toothbrush with repeated oral hygiene instructions (OHI) and motivation (Group M1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Powered rotating-oscillating toothbrush without repeated oral hygiene instructions (OHI) and motivation (Group E2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual toothbrush without repeated oral hygiene instructions (OHI) and motivation (Group M2)
Number of subjects: 60
Study: 22256777

Group type: EXPERIMENTAL
Intervention: Pure aglycone form of genistein (GEN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucoside form of genistein (GEN)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aglycone form of genistein (GEN)
Number of subjects: 0
Study: 20585816

Group type: EXPERIMENTAL
Intervention: Self-exercise every day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Joint mobilization by physical therapists in the hospital setting
Number of subjects: 120

Group type: COMPARATOR
Intervention: Group with more than 7 months of the condition
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dominant-handed group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Age group 71 years and above
Number of subjects: 120

Group type: COMPARATOR
Intervention: Frequency of sessions for joint mobilization
Number of subjects: 120
Study: 18284435

Group type: EXPERIMENTAL
Intervention: Troglitazone (200 mg/day) for 12 weeks
Number of subjects: 39
Study: 16187007

Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg daily
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 12494068

Group type: EXPERIMENTAL
Intervention: Atenolol (20 patients)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (8 patients)
Number of subjects: 28
Study: 10459816

Group type: EXPERIMENTAL
Intervention: Isepamicin 25 mg/kg on the first day followed by 15 mg/kg od for 4 days
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Isepamicin 15 mg/kg od for 5 days
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Isepamicin 15 mg/kg od for 10 days
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Isepamicin dosing regimens
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Isepamicin 24 h trough level at day 1
Number of subjects: 196
Study: 7541236

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1200 mg day‐1 for 7 days)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2193200

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 213

Group type: COMPARATOR
Intervention: Cefuroxime
Number of subjects: 213
Study: 525840

Group type: EXPERIMENTAL
Intervention: Injection of a parasympatholytic agent
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Heavy morphinic analgesia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Retrobulbar block
Number of subjects: 80
Study: 31881421

Group type: EXPERIMENTAL
Intervention: Biophilic indoor environments
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-biophilic environment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Different types of biophilic environments
Number of subjects: 100
Study: 30790323

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided closed reduction and fixation
Number of subjects: 24

Group type: COMPARATOR
Intervention: C-arm fluoroscopy-assisted fixation
Number of subjects: 24
Study: 28133855

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil (EVOO)
Number of subjects: 7403

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with nuts
Number of subjects: 7403

Group type: COMPARATOR
Intervention: Low-fat control diet
Number of subjects: 7403
Study: 26524046

Group type: EXPERIMENTAL
Intervention: Multigly‐cosidorum Tripterygium combined with rhIL‐11
Number of subjects: 75

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 75
Study: 24313873

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg (intravenous and oral) administered on two occasions
Number of subjects: 0
Study: 22075754

Group type: EXPERIMENTAL
Intervention: Laser-sintered Co-Cr structures with resin-modified glass-ionomer cement
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Laser-sintered Co-Cr structures with acrylic/urethane-based cement
Number of subjects: 48

Group type: COMPARATOR
Intervention: Vacuum-cast Co-Cr, Ni-Cr-Ti, and Pd-Au structures with self-adhesive cement
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: All alloy groups
Number of subjects: 48
Study: 18978501

Group type: EXPERIMENTAL
Intervention: Cannabis plant extract (Sativex)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 17427836

Group type: EXPERIMENTAL
Intervention: Statin therapy, specific dosage and duration not available
Number of subjects: 0
Study: 15899725

Group type: EXPERIMENTAL
Intervention: Cyclosporine microemulsion with sirolimus
Number of subjects: 22

Group type: COMPARATOR
Intervention: Tacrolimus capsules with sirolimus
Number of subjects: 22
Study: 12504399

Group type: EXPERIMENTAL
Intervention: Sulfadoxine/pyrimethamine plus amodiaquine
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Sulfadoxine/pyrimethamine plus artesunate
Number of subjects: 316

Group type: COMPARATOR
Intervention: Sulfadoxine/pyrimethamine alone
Number of subjects: 316
Study: 11475731

Group type: EXPERIMENTAL
Intervention: Cassia angustifolia extract (CAE) enema administration
Number of subjects: 130
Study: 7644655

Group type: EXPERIMENTAL
Intervention: Thallium-201 scintigraphy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Gallium-67 scans
Number of subjects: 33
Study: 2529294

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 155292

Group type: EXPERIMENTAL
Intervention: Combination of ipratropium bromide (IPTB) and disodium cromoglycate (DSCG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ipratropium bromide (IPTB)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Disodium cromoglycate (DSCG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Isotonic saline (placebo)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fenoterol (beta-adrenergic agonist)
Number of subjects: 18
Study: 31924637

Group type: EXPERIMENTAL
Intervention: Comprehensive intervention including government engagement, health education, and targeting restaurants, home cooks, and primary school students and their families; implemented for 1 year.
Number of subjects: 2688

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 2688
Study: 29966229

Group type: EXPERIMENTAL
Intervention: Essence of Chicken (EC)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study: 26520171

Group type: EXPERIMENTAL
Intervention: Topical 0.1% fluorometholone (FML)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Topical polyvinyl alcohol (PA)
Number of subjects: 41
Study: 25231240

Group type: EXPERIMENTAL
Intervention: Laparoscopic sacrohysteropexy
Number of subjects: 124

Group type: COMPARATOR
Intervention: Vaginal sacrospinous hysteropexy
Number of subjects: 124
Study: 22488578

Group type: EXPERIMENTAL
Intervention: ICG-augmented diode laser therapy (808 nm) with ICG (2 mg/kg body weight) and diode laser pulses (50-110 J/cm²)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Diode laser therapy without ICG
Number of subjects: 15

Group type: COMPARATOR
Intervention: Pulsed dye laser (PDL) treatment
Number of subjects: 15
Study: 20413297

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 2 years
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 5 years
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Tamoxifen for 5 years with high VEGF
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Tamoxifen (overall population)
Number of subjects: 402
Study: 18394111

Group type: EXPERIMENTAL
Intervention: Friend social support
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Friend social support change factor
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: BMI change factor
Number of subjects: 193
Study: 15816590

Group type: EXPERIMENTAL
Intervention: ProSeal Laryngeal Mask Airway (PLMA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Laryngeal Tube Suction (LTS)
Number of subjects: 50
Study: 11958302

Group type: EXPERIMENTAL
Intervention: BRAT2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequestra
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Compact Advanced
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cell Saver 5 (CS5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous Autologous Transfusion System (CATS)
Number of subjects: 0
Study: 11054990

Group type: EXPERIMENTAL
Intervention: Vitamin C; specific dosage and duration not mentioned
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 8790030

Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) - dietary recommendations, antihypertensive drugs, counseling for smoking cessation
Number of subjects: 12866

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 12866

Group type: EXPERIMENTAL
Intervention: Special Intervention (SI)
Number of subjects: 12866
Study: 1986601

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 27

Group type: COMPARATOR
Intervention: Nylidrin
Number of subjects: 27
Study: 6360750

Group type: EXPERIMENTAL
Intervention: Fenoprofen 600 mg, four times daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg, four times daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fenoprofen 600 mg, four times daily (combined data from Weeks 1 and 2)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ibuprofen 400 mg, four times daily (combined data from Weeks 1 and 2)
Number of subjects: 50
Study: 31519360

Group type: EXPERIMENTAL
Intervention: Peritoneal Lavage (PL)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Suction Only (SO)
Number of subjects: 86
Study: 29315667

Group type: EXPERIMENTAL
Intervention: Temporary constraints between near-colliding links
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized Poisson-disk motion planner
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Algorithm for correlated protein motions
Number of subjects: 0
Study: 26654956

Group type: EXPERIMENTAL
Intervention: Client-centred activities in daily living intervention (CADL)
Number of subjects: 6
Study: 25972101

Group type: EXPERIMENTAL
Intervention: Cefazolin (single intravenous dose)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (no antibiotic prophylaxis)
Number of subjects: 500
Study: 23217479

Group type: EXPERIMENTAL
Intervention: Single dose of pre-operative antibiotics (cefuroxime sodium and metronidazole)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Postoperative antibiotics (same antibiotics as group A)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Single dose of pre-operative antibiotics (cefuroxime and metronidazole)
Number of subjects: 377
Study: 20652627

Group type: EXPERIMENTAL
Intervention: Dronedarone (400 mg or 800 mg once daily or 600 mg twice daily)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 124
Study: 18520806

Group type: EXPERIMENTAL
Intervention: Weekly intravenous cetuximab (initial dose 400mg/m2; maintenance dose 250 mg/m2) with concomitant radiotherapy (64Gy/32 fractions/45 days)
Number of subjects: 12
Study: 15637747

Group type: EXPERIMENTAL
Intervention: Pancreatic enzyme replacement
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 20
Study: 12069179

Group type: EXPERIMENTAL
Intervention: Hepatic dysfunction (HD+) subgroup
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-hepatic dysfunction (HD-) subgroup
Number of subjects: 26
Study: 10431879

Group type: EXPERIMENTAL
Intervention: Topical ciprofloxacin
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control (no ciprofloxacin)
Number of subjects: 154
Study: 8776071

Group type: EXPERIMENTAL
Intervention: Intense training programme
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Moderate training programme
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (20 subjects)
Number of subjects: 121
Study: 2246493

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6286734

Group type: EXPERIMENTAL
Intervention: Combination of enalapril (5 or 10 mg) and hydrochlorothiazide (50 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Enalapril (5 or 10 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (50 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30811444

Group type: EXPERIMENTAL
Intervention: Isolated core exercises (prone bridge, side bridge, back extension)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Integrated core exercises (lunges on stable surface, unstable surface, with external resistance)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lunges with elastic bands
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unstable lunges
Number of subjects: 0
Study: 28322359

Group type: EXPERIMENTAL
Intervention: Laser + acid etching
Number of subjects: 51

Group type: COMPARATOR
Intervention: Acid etching
Number of subjects: 51
Study: 25727718

Group type: EXPERIMENTAL
Intervention: BCRL group (n=15)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: No BCRL group (n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n=24)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall (n=30)
Number of subjects: 30
Study: 25130995

Group type: COMPARATOR
Intervention: STAS (short-term androgen suppression with leuprorelin for 6 months and radiotherapy)
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: STAS plus zoledronic acid (4 mg every 3 months for 18 months, intravenously)
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: ITAS (intermediate-term androgen suppression with leuprorelin for 18 months and radiotherapy)
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: ITAS plus zoledronic acid
Number of subjects: 1071

Group type: COMPARATOR
Intervention: STAS
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: STAS plus zoledronic acid
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: ITAS
Number of subjects: 1071
Study: 22895556

Group type: EXPERIMENTAL
Intervention: Low-dose decitabine plus aclacinomycin/cytarabine (DAA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aclacinomycin/cytarabine (AA)
Number of subjects: 20
Study: 19774307

Group type: EXPERIMENTAL
Intervention: Locomotor training with an electromechanical gait device
Number of subjects: 16

Group type: COMPARATOR
Intervention: Treadmill or task-oriented gait training
Number of subjects: 16
Study: 21611946

Group type: EXPERIMENTAL
Intervention: 22G needle
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: 25G needle
Number of subjects: 127
Study: 16143730

Group type: EXPERIMENTAL
Intervention: Ketamine (0.23 mg/kg IV followed by 0.5 mg/kg infusion)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Amphetamine (0.25 mg/kg infusion)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ketamine and Amphetamine (combined effects)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Saline (control for ketamine)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Saline (control for amphetamine)
Number of subjects: 41
Study: 12355581

Group type: EXPERIMENTAL
Intervention: Dialon (Julphar, UAE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Glucophage (Lipha Pharmaceutical Industries, France)
Number of subjects: 24